QTTB Q32 Bio Inc.

NASDAQ
$8.77

Q32 Bio Inc. (QTTB) is expected to report earnings on November 4, 2026, before the market open. The consensus earnings estimate is a loss of $0.36 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -45.7% since its last earnings release on August 5, 2026.

Q32 Bio Beat Consensus Estimates
Wednesday, August 5, 2026 · 6:59 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.36)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.13

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Q32 Bio Inc.

Q32 Bio Inc. is a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis. Q32 Bio Inc., formerly known as Homology Medicines Inc., is based in WALTHAM, Mass.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.